Chemung Financial Corporation Reports Third Quarter 2025 Net Income of $7.8 million, or $1.62 per share GlobeNewswire October 21, 2025 ELMIRA, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) — Chemung Financial Corporation (the “Corporation”) (Nasdaq: CHMG), the parent company of Chemung Canal Trust Company (the “Bank”), today reported net income of $7.8 million, or $1.62 per […]
Meta announces joint venture with funds managed by Blue Owl Capital to finance the development and conduct the operations of the Hyperion data center campus in Richland Parish, Louisiana Meta Platforms, Inc. (NASDAQ: META) and funds managed by Blue Owl Capital entered into a joint venture agreement which will develop and own the Hyperion data
Ramaco Resources, Inc. (NASDAQ: METC, METCB, “Ramaco” or the “Company”) will report third quarter 2025 financial results on Monday, October 27, 2025 after the close of market. The earnings news release will be available on the Company's investor relations website atwww.ramacoresources.com and through major financial information sites. At 9:00 a.m. Eastern Time on Tuesday, October
Orrstown Financial Services, Inc. Reports Third Quarter 2025 Results GlobeNewswire October 21, 2025 Net income of $21.9 million, or $1.13 per diluted share, for the three months ended September 30, 2025 compared to net income of $19.4 million, or $1.01 per diluted share, for the three months ended June 30, 2025; excluding the impact of
The Board of Directors of The Sherwin-Williams Company (NYSE: SHW) today announced a regular quarterly dividend of $0.79 per common share payable on December 5, 2025, to shareholders of record on November 14, 2025. https://mma.prnewswire.com/media/346043/The_Sherwin_Williams_Company_Logo.jpg Investor Relations Contacts: Media Contact:JimJaye Julie YoungSenior Vice President, Investor Relations & Vice President, Global CorporateCorporate Communications CommunicationsSherwin-Williams Sherwin-WilliamsDirect: 216.515.8682
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire October 21, 2025 CONSHOHOCKEN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on October 15, 2025 to 19 new
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire October 21, 2025 CONSHOHOCKEN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on October 15, 2025 to 19 new
Postal Realty Trust, Inc. to Report Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 CEDARHURST, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) — Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real estate investment trust that owns and manages over 2,200 properties leased primarily to the United States
Postal Realty Trust, Inc. to Report Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 CEDARHURST, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) — Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real estate investment trust that owns and manages over 2,200 properties leased primarily to the United States
Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update GlobeNewswire October 21, 2025 SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of